According to data from Statistics Korea, cancer accounted for the majority of deaths in Korea in 2021, constituting 26% of all recorded cases. Similarly, cancer was the primary cause of death in 2020. Among the various types ...
Aug 14, 2023
0
1
Cells use a variety of metabolic pathways to synthesize the building blocks for growth and proliferation. To ensure balanced growth, these biosynthetic processes must be tightly coordinated. Researchers from the Max Planck ...
Aug 10, 2023
0
16
In a recent study published in the journal of Genes & Diseases, Research team led by Lu explores the potential for the use of FDA-approved hypertension and EMA-approved cough medicines to revolutionize cancer treatment.
Aug 10, 2023
0
4
A new study of mice and lab-grown human colon "organoids" indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical ...
Aug 10, 2023
0
38
While there are highly effective treatments for the hepatitis C virus (HCV), only one in five Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell ...
Aug 10, 2023
0
1
People who take acid reflux medications called proton pump inhibitors for four-and-a-half years or more may have a higher risk of dementia compared to people who do not take these medications, according to new research published ...
Aug 9, 2023
0
32
Losing weight conveniently, cheaply, safely. That's been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting's 1863 Letter on Corpulence promoted his "miraculous" ...
Aug 9, 2023
0
3
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. Systemic sclerosis (SSc) or scleroderma is another rheumatic autoimmune disease that affects blood vessels, skin, ...
Aug 8, 2023
0
1
Mutations in a genetic region that regulates RNA stability could influence prostate cancer outcomes and drug resistance, according to new work from scientists at Fred Hutchinson Cancer Center published in Cell Reports.
Aug 7, 2023
0
65
The U.S. Food and Drug Administration has approved RiVive, an over-the-counter (OTC) naloxone hydrochloride nasal spray for emergency treatment of known or suspected opioid overdose.
Aug 4, 2023
0
10
